Capable managers and expansive resources support Hartford Balanced Income’s disciplined approach, but some shares’ big price tags reduce the appeal.
Hartford Balanced Income Y HBLYX
- NAV / 1-Day Return 15.39 / 0.00
- Total Assets 12.6 Bil
-
Adj. Expense Ratio
- Expense Ratio 0.660%
- Distribution Fee Level Average
- Share Class Type Institutional
- Category Moderately Conservative Allocation
- Investment Style Large Value
- Credit Quality / Interest Rate Sensitivity Medium/Moderate
- Status Open
- TTM Yield 3.51%
- Turnover 57%
USD | NAV as of Oct 04, 2024 | 1-Day Return as of Oct 04, 2024, 10:29 PM GMT+0
Morningstar’s Analysis HBLYX
Will HBLYX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 11.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Usd | 1.64 | 208.6 Mil | Cash and Equivalents |
JPMorgan Chase & Co | 1.59 | 202.3 Mil | Financial Services |
UnitedHealth Group Inc | 1.41 | 179.0 Mil | Healthcare |
Pfizer Inc | 1.37 | 174.0 Mil | Healthcare |
ConocoPhillips | 1.35 | 171.4 Mil | Energy |
Johnson & Johnson | 1.27 | 161.2 Mil | Healthcare |
2 Year Treasury Note Future Dec 24 | 1.16 | 147.4 Mil | Government |
Cisco Systems Inc | 0.97 | 123.1 Mil | Technology |
Merck & Co Inc | 0.89 | 113.0 Mil | Healthcare |
Gilead Sciences Inc | 0.87 | 111.4 Mil | Healthcare |